Sedation Management

Pharmacological Interventions

• When midazolam alone is insufficient, adding an opioid analgesic (e.g., fentanyl) for pain control is recommended, as per the Intensive Care Medicine guidelines and the American College of Emergency Physicians 1, 2
• The combination of intravenous midazolam and fentanyl provides effective procedural sedation and analgesia, reducing pain, anxiety, and creating amnesia while maintaining patient safety, with high efficacy rates of 91-100% for procedural sedation 2, 3
• Both medications should be titrated slowly to achieve the desired level of sedation while minimizing adverse effects, with the American Society of Anesthesiologists recommending careful titration 2
• The primary concern with this combination is respiratory depression due to synergistic effects, highlighting the need for careful monitoring, with approximately 10-20% of patients experiencing mild respiratory events requiring oxygen or stimulation 3
• Midazolam is the preferred short-acting benzodiazepine for IV administration due to its rapid onset and short duration of action, making it ideal for procedural sedation, as recommended by the American Academy of Pediatrics and the European Society for Medical Oncology 4, 5
• The dosing for midazolam is 0.5-1 mg/h IV, with 1-5 mg as needed, and has a rapid onset of action, typically within 1-2 minutes, and a duration of action of 30-60 minutes 5, 6
• The following medication guidelines are recommended:

6

• Propofol can be considered as a second-line agent for sedation, with a rapid onset and recovery, but requires careful monitoring for respiratory depression, as reported by the American Gastroenterological Association and the British Medical Journal 1, 6, 7
• Dexmedetomidine is associated with less delirium than benzodiazepines and allows for better patient communication, as noted by the British Medical Journal, and non-benzodiazepine sedatives like propofol and dexmedetomidine are preferred in ICU settings due to improved outcomes 7, 3

Special Considerations

• Elderly patients require dose reduction (typically 50% or more) due to increased sensitivity to benzodiazepines, and have reduced midazolam clearance, increasing the risk of respiratory depression, as recommended by the American Geriatrics Society and reported by 8, 6
• Patients with respiratory compromise should use lorazepam with caution due to the risk of respiratory depression, and identification of high-risk patients, such as the elderly (>60 years), obese, patients with hepatic or renal dysfunction, or underlying respiratory conditions, is crucial for safe sedation practices, as suggested by 9, 10, 11, 8
• Patients with hepatic or renal dysfunction should have their dose reduced by 25-50%, as suggested by the European Association of Urology 12
• Lorazepam is contraindicated in patients with acute alcohol intoxication, as reported by 9

Monitoring and Reversal

• Continuous monitoring of oxygen saturation, respiratory rate, and blood pressure is essential when administering benzodiazepines, as recommended by the American Society of Anesthesiologists and the American Heart Association 12, 3
• Having a reversal agent, such as flumazenil, immediately available is crucial in case of an emergency, as suggested by the European Society of Anaesthesiology and the American Heart Association 12, 3

Non-Pharmacological Interventions

• Breathing exercises, such as instructing patients to inhale slowly through the nose and exhale slowly through pursed lips, starting 5 minutes before the scan, can be an effective relaxation technique for patients undergoing CT scans, as recommended by the European Society of Radiology 13
• Audio-visual entertainment can significantly reduce anxiety in patients undergoing CT scans, according to the European Journal of Nuclear Medicine and Molecular Imaging 14